AU2003248405B2 - Genetic engineering of lignin biosynthesis in plants - Google Patents
Genetic engineering of lignin biosynthesis in plants Download PDFInfo
- Publication number
- AU2003248405B2 AU2003248405B2 AU2003248405A AU2003248405A AU2003248405B2 AU 2003248405 B2 AU2003248405 B2 AU 2003248405B2 AU 2003248405 A AU2003248405 A AU 2003248405A AU 2003248405 A AU2003248405 A AU 2003248405A AU 2003248405 B2 AU2003248405 B2 AU 2003248405B2
- Authority
- AU
- Australia
- Prior art keywords
- plant
- species
- lignin
- transgenic
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229920005610 lignin Polymers 0.000 title claims description 146
- 230000015572 biosynthetic process Effects 0.000 title description 22
- 238000010353 genetic engineering Methods 0.000 title description 6
- 241000196324 Embryophyta Species 0.000 claims description 253
- 230000009261 transgenic effect Effects 0.000 claims description 99
- 238000000034 method Methods 0.000 claims description 55
- 230000014509 gene expression Effects 0.000 claims description 51
- 239000001913 cellulose Substances 0.000 claims description 44
- 229920002678 cellulose Polymers 0.000 claims description 44
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 claims description 32
- 108090000364 Ligases Proteins 0.000 claims description 31
- 108020004511 Recombinant DNA Proteins 0.000 claims description 29
- 102000053602 DNA Human genes 0.000 claims description 26
- 102000003960 Ligases Human genes 0.000 claims description 18
- 230000000692 anti-sense effect Effects 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 241000894007 species Species 0.000 claims description 15
- 208000035240 Disease Resistance Diseases 0.000 claims description 12
- 241000218922 Magnoliophyta Species 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 241000219000 Populus Species 0.000 claims description 6
- 241000218631 Coniferophyta Species 0.000 claims description 5
- 230000003247 decreasing effect Effects 0.000 claims description 5
- 241000208140 Acer Species 0.000 claims description 3
- 240000007472 Leucaena leucocephala Species 0.000 claims description 3
- 241000218657 Picea Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 2
- 108091033319 polynucleotide Proteins 0.000 claims 12
- 102000040430 polynucleotide Human genes 0.000 claims 12
- 239000002157 polynucleotide Substances 0.000 claims 12
- NGSWKAQJJWESNS-ZZXKWVIFSA-M trans-4-coumarate Chemical compound OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 claims 4
- 241000219429 Betula Species 0.000 claims 2
- 241000722891 Callitris Species 0.000 claims 2
- 241000723418 Carya Species 0.000 claims 2
- 241000219501 Casuarina Species 0.000 claims 2
- 244000166124 Eucalyptus globulus Species 0.000 claims 2
- 241000758789 Juglans Species 0.000 claims 2
- 241000218602 Pinus <genus> Species 0.000 claims 2
- 241000218683 Pseudotsuga Species 0.000 claims 2
- 241000219492 Quercus Species 0.000 claims 2
- 241000218685 Tsuga Species 0.000 claims 2
- 241001106462 Ulmus Species 0.000 claims 2
- 230000001172 regenerating effect Effects 0.000 claims 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 description 55
- 241000183024 Populus tremula Species 0.000 description 48
- 210000004027 cell Anatomy 0.000 description 44
- 210000001519 tissue Anatomy 0.000 description 41
- 230000000694 effects Effects 0.000 description 32
- 239000002023 wood Substances 0.000 description 29
- 239000002299 complementary DNA Substances 0.000 description 27
- 230000012010 growth Effects 0.000 description 27
- 230000002829 reductive effect Effects 0.000 description 21
- 239000012634 fragment Substances 0.000 description 20
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 18
- 230000003828 downregulation Effects 0.000 description 17
- 230000037361 pathway Effects 0.000 description 17
- 230000009467 reduction Effects 0.000 description 17
- 229930015704 phenylpropanoid Natural products 0.000 description 16
- 230000001105 regulatory effect Effects 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 14
- 240000004923 Populus tremuloides Species 0.000 description 12
- 235000011263 Populus tremuloides Nutrition 0.000 description 12
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 12
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 12
- 210000002421 cell wall Anatomy 0.000 description 11
- 230000009466 transformation Effects 0.000 description 11
- 108020004635 Complementary DNA Proteins 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 229920001503 Glucan Polymers 0.000 description 10
- 206010020649 Hyperkeratosis Diseases 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 10
- 229940093681 4-coumaric acid Drugs 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 9
- JMFRWRFFLBVWSI-NSCUHMNNSA-N coniferol Chemical compound COC1=CC(\C=C\CO)=CC=C1O JMFRWRFFLBVWSI-NSCUHMNNSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 235000011197 perejil Nutrition 0.000 description 9
- 244000061176 Nicotiana tabacum Species 0.000 description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 8
- 241000208317 Petroselinum Species 0.000 description 8
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 210000001339 epidermal cell Anatomy 0.000 description 8
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 101150029435 4CL gene Proteins 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 7
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 7
- 235000001785 ferulic acid Nutrition 0.000 description 7
- 229940114124 ferulic acid Drugs 0.000 description 7
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 7
- 229930027917 kanamycin Natural products 0.000 description 7
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
- 229960000318 kanamycin Drugs 0.000 description 7
- 229930182823 kanamycin A Natural products 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 7
- 108020005029 5' Flanking Region Proteins 0.000 description 6
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 244000061456 Solanum tuberosum Species 0.000 description 6
- 235000002595 Solanum tuberosum Nutrition 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- LZFOPEXOUVTGJS-ONEGZZNKSA-N trans-sinapyl alcohol Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O LZFOPEXOUVTGJS-ONEGZZNKSA-N 0.000 description 6
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 241000218679 Pinus taeda Species 0.000 description 5
- 235000008566 Pinus taeda Nutrition 0.000 description 5
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 5
- 235000004883 caffeic acid Nutrition 0.000 description 5
- 229940074360 caffeic acid Drugs 0.000 description 5
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 230000011987 methylation Effects 0.000 description 5
- 238000007069 methylation reaction Methods 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- YFXWTVLDSKSYLW-NSCUHMNNSA-N (E)-5-hydroxyferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(O)=C1O YFXWTVLDSKSYLW-NSCUHMNNSA-N 0.000 description 4
- 241000219194 Arabidopsis Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108010067661 Caffeate O-methyltransferase Proteins 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 4
- 229940088530 claforan Drugs 0.000 description 4
- 229940119526 coniferyl alcohol Drugs 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000004459 forage Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000001474 phenylpropanoid group Chemical group 0.000 description 4
- 230000008635 plant growth Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010016192 4-coumarate-CoA ligase Proteins 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 108010074879 Cinnamoyl-CoA reductase Proteins 0.000 description 3
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 229920002488 Hemicellulose Polymers 0.000 description 3
- 238000012565 NMR experiment Methods 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 108010036937 Trans-cinnamate 4-monooxygenase Proteins 0.000 description 3
- 239000007640 basal medium Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 235000013985 cinnamic acid Nutrition 0.000 description 3
- LZFOPEXOUVTGJS-UHFFFAOYSA-N cis-sinapyl alcohol Natural products COC1=CC(C=CCO)=CC(OC)=C1O LZFOPEXOUVTGJS-UHFFFAOYSA-N 0.000 description 3
- 230000001447 compensatory effect Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000006353 environmental stress Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 244000053095 fungal pathogen Species 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 229930014251 monolignol Natural products 0.000 description 3
- 125000002293 monolignol group Chemical group 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000002786 root growth Effects 0.000 description 3
- 230000024053 secondary metabolic process Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- YFXWTVLDSKSYLW-UHFFFAOYSA-N (E)-3,4-dihydroxy-5-methoxycinnamic acid Natural products COC1=CC(C=CC(O)=O)=CC(O)=C1O YFXWTVLDSKSYLW-UHFFFAOYSA-N 0.000 description 2
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- 238000003979 3D HSQC-TOCSY Methods 0.000 description 2
- 101150062300 4CL2 gene Proteins 0.000 description 2
- 239000005972 6-Benzyladenine Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 101000761279 Oryza sativa subsp. japonica 4-coumarate-CoA ligase 2 Proteins 0.000 description 2
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 229930183415 Suberin Natural products 0.000 description 2
- HFCYZXMHUIHAQI-UHFFFAOYSA-N Thidiazuron Chemical compound C=1C=CC=CC=1NC(=O)NC1=CN=NS1 HFCYZXMHUIHAQI-UHFFFAOYSA-N 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000001994 activation Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 108010002685 hygromycin-B kinase Proteins 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000280 phytoalexin Substances 0.000 description 2
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000019525 primary metabolic process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000002098 selective ion monitoring Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 235000021286 stilbenes Nutrition 0.000 description 2
- 150000001629 stilbenes Chemical class 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 150000004823 xylans Chemical group 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- QMPOHKDJNKTEHF-UHFFFAOYSA-N 2-phenyl-2,3-dihydro-1-benzofuran Chemical group O1C2=CC=CC=C2CC1C1=CC=CC=C1 QMPOHKDJNKTEHF-UHFFFAOYSA-N 0.000 description 1
- -1 4CL Proteins 0.000 description 1
- 101150001464 4CL1 gene Proteins 0.000 description 1
- 244000283070 Abies balsamea Species 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 235000014466 Douglas bleu Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 241000218314 Liriodendron tulipifera Species 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- XCOBLONWWXQEBS-KPKJPENVSA-N N,O-bis(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 240000001416 Pseudotsuga menziesii Species 0.000 description 1
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101100084449 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PRP4 gene Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N THREONINE Chemical compound CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 108091060592 XDNA Proteins 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008166 cellulose biosynthesis Effects 0.000 description 1
- 108010040093 cellulose synthase Proteins 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000012877 elongation medium Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 238000009815 homocoupling reaction Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002015 leaf growth Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 230000009663 quantitative growth Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000034655 secondary growth Effects 0.000 description 1
- RBFUWESMWRUGFY-GSNIOFLCSA-N sinapoyl-CoA Chemical compound COC1=C(O)C(OC)=CC(\C=C\C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)OP(O)(O)=O)=C1 RBFUWESMWRUGFY-GSNIOFLCSA-N 0.000 description 1
- 239000012354 sodium borodeuteride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000036435 stunted growth Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 238000001551 total correlation spectroscopy Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 230000013717 xylem development Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8255—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
- C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Description
AUSTRALIA
Patents Act 1990 COMPLETE SPECIFICATION STANDARD PATENT Applicant(s): BOARD OF CONTROL OF MICHIGAN TECHNOLOGICAL UNIVERSITY Invention Title: GENETIC ENGINEERING OF LIGNIN BIOSYNTHESIS IN PLANTS The following statement is a full description of this invention, including the best method of performing it known to me/us: 1- The entire disclosure in the complete specification of our Australian Patent Application No.
14024/99 is by this cross-reference incorporated into the present specification.
Field of the Invention The invention relates to genetically modifying plants, e.g. trees, through manipulation of the lignin biosynthesis pathway, and more particularly, to genetically modifying plants through the down regulation of 4-coumarate Co-enzyme A ligase (4CL) to achieve faster growth. Down regulation of 4CL may also achieve altered lignin content, and/or altered lignin structure, and/or altered cellulose content, and/or altered disease resistance of the trees. Moreover, promoters of the 4CL genes are useful to drive gene expression specifically in xylem tissue or specifically in epidermal tissues.
Background of the Invention All references, including any patents or patent applications, cited in this specification are hereby incorporated by reference. No admission is made that any reference constitutes prior art. The discussion of the references states what their authors assert, and the applicants reserve the right to challenge the accuracy and pertinency of the cited documents. It will be clearly understood that, although a number of prior art publications are referred to herein, this reference does not constitute an admission that any of these documents forms part of the common general knowledge in the art, in Australia or in any other country.
Genetic engineering of plants to conform to desired traits has shifted the emphasis in plant improvement away from the traditional breeding programs during the past decade. Although research on genetic engineering of plants has been vigorous, the progress has been slow.
H:\RBe11\Keep\P50868 .doc 26/09/03 2 The ability to make plants grow faster continues to be the top objective of many companies worldwide, The ability to genetically increase the optimal growth of plants would be a commercially significant improvement.
Faster growing plants could be used by all sectors of the agriculture and forest products industries worldwide.
Lignin, a complex phenolic polymer, is a major component in cell walls of secondary xylem. In general, lignin constitutes 25% of the dry weight of the wood, making it the second most abundant compound on earth after cellulose. Although lignin plays an important role in plants, it usually represents an obstacle to utilising biomass in several applications. For example, in wood pulp production, lignin has to be removed through expensive and polluting processes in order to recover cellulose.
Thus it is desirable to genetically engineer plants with reduced lignin content and/or altered lignin composition that can be utilized more efficiently. Plants that could be genetically engineered with a reduced amount of lignin would be commercially valuable. These genetically engineered plants would be less expensive to pulp because, in essence, part of the pulping has already been performed due to the reduced amount of lignin.
Further, plants with increased cellulose content would also be commercially valuable to the pulp and paper industry.
Disease resistance in plants is also a desirable plant trait. The impact of disease resistance in plants on the economy of plant products industry worldwide is significant.
Thus, what is needed is the identification and characterisation of genes useful to enhance plant growth, alter lignin content and/or structure in plants, alter cellulose content in plants, and/or provide or enhance resistance of plants.
For the purposes of this specification it will be clearly understood that the word "comprising" H:\RBe11\Keep\P50868.doc 26/09/03 2ameans "including but not limited to", and that the word "comprises" has a corresponding meaning.
Summary of the Invention The invention provides a method to genetically alter plants through the down regulation (decrease) or inhibition of native (endogenous) 4-coumarate Co-enzyme A ligase (4CL) in that plant. Such down regulation of 4coumarate Co-enzyme A ligase results in faster growth, and/or reduced lignin content, and/or altered lignin structure, and/or altered cellulose content, and/or altered disease resistance in the genetically altered plant. The invention also provides for genetically engineered plants, transformed or transgenic plants, which have been altered to down regulate or inhibit native 4-coumarate Coenzyme A ligase in the plant so as to achieve faster growth, and/or reduced lignin content, and/or altered lignin structure, and/or increased cellulose content, and/or increased disease resistance. Preferred genetically altered plants include trees, e.g. angiosperms or gymnosperms, forage crops, and more preferably a forest tree, Populus. Preferred angiosperms include, but are not limited to, Populus, Acacia, Sweetgum, yellow poplar, maple and birch, including pure H:\RBell\Keep\P50868.doc 26/09/03 lines and hybrids thereof. Preferred gymosperms include, but are not limited to, Pine, Spruce, Douglas-fir and hemlock.
The invention further provides a transgenic plant, the genome of which is augmented by a recombinant DNA molecule encoding 4-coumarate Co-enzyme A ligase, or a recombinant DNA molecule comprising an antisense 4-coumarate Co-enzyme A ligase gene, or a fragment thereof. The recombinant DNA molecule is expressed so as to down regulate, decrease or inhibit lignin pathway 4-coumarate Co-enzyme A ligase.
The invention also provides an isolated and purified DNA molecule comprising a DNA segment comprising a transcriptional regulatory control region of a 4-coumarate Co-enzyme A ligase gene. Preferably, the transcriptional regulatory region comprises a promoter. Tissue specific promoters of a 4-coumarate Co-enzyme A ligase gene can be used to manipulate gene expression in target tissue such as xylem and epidermal tissues, as described hereinbelow. Preferably, the promoter is derived from aspen DNA.
Therefore, the invention also provides an expression cassette comprising a transcriptional regulatory region of a 4-coumarate co-enzyme A ligase gene, a method of using the region to express a preselected DNA segment in a tissuespecific manner in plant cells, and a transgenic plant comprising the expression cassette.
Also provided is a method to alter, enhance, plant growth. The method comprises introducing an expression cassette into cells of a plant, e.g., the cells of a tree, so as to yield genetically altered plant cells. The expression cassette comprises a recombinant DNA molecule, segment, or sequence, comprising a 4-coumarate Co-enzyme A ligase gene, or a fragment thereof.
Preferably, the 4-coumarate Co-enzyme A ligase gene, or fragment thereof, is in antisense orientation. The 4-coumarate Co-enzyme A ligase gene may be a homologous or heterologous 4-coumarate Co-enzyme A ligase gene. The transformed plant cells are regenerated to provide a genetically altered, e.g., transgenic, plant. The recombinant DNA is expressed in the cells of the regenerated, genetically altered plant in an amount that confers enhanced or accelerated growth tothe regenerated, genetically altered plant relative to the corresponding non-genetically altered plant. Preferably, the genetically altered plant is a tree. It is preferred that a genetically altered tree of the invention has an increase in height, leaf size, diameter and/or average internode length relative to the corresponding non-genetically altered tree.
Hence, the invention also provides for a genetically altered plant, the genome of which is augmented by a recombinant DNA molecule encoding 4coumarate Co-enzyme A ligase, or a recombinant DNA molecule comprising an antisense 4-coumarate Co-enzyme A ligase gene, or fragment thereof, which plant has altered growth characteristics relative to the corresponding nongenetically altered plant.
Further provided is a method to genetically alter plants so as to change or alter their lignin structure. The method comprises introducing an expression cassette into cells of a plant, a tree, so as to yield genetically altered plant cells. The expression cassette preferably comprises an antisense recombinant DNA molecule, segment or sequence comprising a 4-coumarate Co-enzyme A ligase gene, or a fragment thereof. The transformed plant cells are regenerated to provide a regenerated, genetically altered plant. The recombinant DNA is expressed in the cells of the regenerated, genetically altered plant in an amount that alters the lignin structure in the cells of the plant relative to the corresponding non-genetically altered plant.
Also provided is a method for altering the lignin content in a plant. The method comprises introducing an expression cassette comprising:a recombinant DNA molecule comprising a 4-coumarate Co-enzyme A ligase gene operably linked to a promoter functional in a plant cell into the cells of a plant. The plant cells are regenerated so as to yield a genetically altered plant. The recombinant DNA molecule is expressed in the cells of the regenerated plant in an amount effective to alter the lignin content in the plant cells. Preferably, the lignin content is reduced. Also preferably, the lignin content is reduced in a tissuespecific manner. In particular, a reduction in lignin content in forage crops is useful as the digestability of these crops by ruminants is increased. Also preferably, the 4-coumarate Co-enzyme A ligase gene is in an antisense orientation relative to the promoter.
Further provided is a genetically altered, transgenic, plant having an altered lignin content in the plant cells. The plant comprises a recombinant DNA molecule comprising a nucleotide sequence encoding a plant 4-coumarate Coenzyme A ligase operably linked to a promoter so that the recombinant DNA molecule is expressed in an amount effective to alter the lignin content of the plant.
Yet another embodiment of the invention is a method to alter, e.g., increase, the cellulose content in plants. The method comprises introducing an expression cassette into cells of a plant, a tree, so as to yield genetically altered plant cells. The expression cassette preferably comprises an antisense recombinant DNA molecule, segment or sequence comprising a 4-coumarate Coenzyme A ligase gene, or a fragment thereof, operably linked to a promoter functional in a plant cell. The transformed plant cells are regenerated to provide a regenerated, genetically altered plant. The recombinant DNA is expressed in the cells of the regenerated, genetically altered plant in an amount that alters the cellulose content in plant. Thus, the invention further provides a genetically altered, transgenic, plant having an altered cellulose content The invention also provides a method to genetically alter plants to increase their disease resistance, to fungal pathogens. The method comprises introducing an expression cassette comprising a recombinant DNA molecule comprising a nucleotide sequence encoding a 4-coumarate Co-enzyme A ligase operably linked to a promoter functional in a plant cell into cells of a plant. The transformed plant cells are regenerated to provide a genetically altered plant. The recombinant DNA molecule is expressed in the cells of the regenerated, genetically altered plant in an amount effective to render the plant resistant to disease. Preferably, the recombinant DNA molecule is expressed in amount that decreases the amount of lignin in the plant and/or increases the amount of phenolic compounds which are toxic to fungal pathogens. Hence, the invention also provides a transgenic plant, which is substantially resistant to disease. The plant comprises a native 4-coumarate Co-enzyme A ligase gene, and a recombinant DNA molecule comprising a nucleotide sequence encoding 4coumarate Co-enzyme A ligase operably linked to a promoter functional in a plant wherein the recombinant DNA molecule is expressed in an amount effective to confer resistance to the transgenic plant.
Other features and advantages of the invention will become apparent to those of ordinary skill in the art upon review of the following drawings, detailed description and claims.
Brief Description of the Drawings Fig. 1 is a schematic of a phenylpropanoid pathway; Fig. 2 is a diagram of Agrobacterium T-DNA gene construct pA4CLI; Fig. 3 is a restriction map of genomic clone Pt4CL1g-4; Fig. 4 is a restriction map of genomic clone Pt4CL2g-11; Fig. 5 is a restriction map of subcloned pT4CLl gene promoter p7Z-4XS; Fig. 6 is a restriction map of subcloned pT4CL2 gene promoter pSK- 11HE; Fig. 7 is an Agrobacterium T-DNA construct of Pt4CL1 promoter and GUS fusion gene Pt4CLlp-GUS; and Fig. 8 is an Agrobacterium T-DNA construct of Pt4CL2 promoter and GUS fusion gene, Pt4CL2p-GUS.
Fig. 9 shows biosynthetic pathways to guaiacyl (coniferyl alcohol 9a) and syringyl (sinapyl alcohol 9b) monolignols for the formation of guaiacyl-syringyl lignin in wood angiosperms. Enzymes are indicated for each reaction step.
C4H, cinnamic acid 4-hydroxylase; C3H, 4-coumaric acid 3-hydroxylase; COMT, caffeic acid O-methyltransferase; F5H, ferulic acid 5-hydroxylase; CCR, cinnamoyl-CoA reductase; CAD, cinnamyl alcohol dehydiogenase. Aspen 4CL (Pt4CL1) converts 4-coumaric 2, caffeic 3, ferulic 4, 5-hydroxyferulic 5, and sinapic 6 acids into their corresponding thioesters for the formation of feruloyl- CoA 7a and sinapoyl-CoA 7b, leading to 9a and 9b, respectively.
Fig. 10. The effects of down-regulation of Pt4CL1 expression on Pt4CL1 activity and lignin accumulation in transgenic aspen. Northern blot analysis ofPt4CLI transcript levels in control (lane C) and transgenic aspen 4, 5, 6, 8, and Each lane contained 20 pg of total RNA extracted from developing xylem and the blot was hybridized (Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, NY (1989)) with Pt4CL1 cDNA. Pt4CL1 enzyme activities in developing xylem tissues.
Crude protein (40 pg) extracted from xylem tissue was assayed spectrophotometically for Pt4CLl activities with various hydroxylated cinnamic acids (Ranjeva et al., 1976). Error bars represent SD values of three replicates.
Levels of lignin reduction in woody stem of transgenic lines as compared to the control, based on the lignin contents presented in Table 7. (D and E) Fluorescence microscopy showing transverse sections of the 20 th internode from control and transgenic line 6 Lignin autofluorescence was visualized following UV-excitation at 365 nm.
Fig. 11 depicts regions of the HSQC spectra (NMR experiments were performed at 360 MHZ on a Bruker DRX-360 using a narrow bore probe with inverse coil geometry (proton coils closest to the sample) and with gradients.
Experiments used were standard Bruker implementations of gradient-selected inverse ('H-detected) HSQC (Palmer et al., J. Magn. Reson. Ser. A, 111, (1991)), HSQC-TOCSY (Braunschweiler et al., J. Magn. Reson., 53, 521 (1983)), and HMQC (Ruiz-Cabello et al., J. Magn. Reson., 100 282 (1992)) along with the standard ID "C (proton-decoupled) and 'H NMR experiments.
TOSCY experiments used a 100 ms spin lock period; HMBC used either an or a 100 ms long-range coupling delay.) of isolated milled wood lignins from (A) control and transgenic line 6. Structure assignments (Ralph et al., 1997) reveal the existence of some major structural units in both samples that are common to angiosperm lignin. The erytho-(6cm:75.4/6.05) and threo- (6c/m:76.6/6.08) isomers of P-aryl ethers 10 are indicated. of coniferyl alcohol 9a involved in dibenzodioxocins 13 (6ca/6:85.3/4.94) (Ralph et al., 1997) was not detected in either sample. Yellow contours are from intense methoxyl signals and light green contours form xylan residues. Other components (gray contours) in both lignin samples, not relevant or not identified, are commonly seen in many other angiosperm lignin preparations.
Fig. 12 shows enhanced growth in transgenic aspen. plants of control and four transgenic aspen grown in a greenhouse (ruler cm). Control and transgenic leaves from the 10* intemodes. (C to F) SE images of stem transverse sections of control [C (bar 50 gtm) and E (bar and transgenic line 6 [D (bar 50 pm) and F (bar 10 gtm)]. 2-weekold ex vitro rooted stem cuttings from control and transgenic aspen lines 5 and 6..
Two cuttings from each line are shown. Leaf upper epidermal cell area.
Values represent the mean of at least 100 determinations per leaf. Sample SD was 15 to 20% of the mean for all determinations.
Before one embodiment of the invention is explained in detail, it is to be understood that the invention is not limited in its application to the details set forth in the following description of the preferred embodiment. The invention is capable of other embodiments and of being practiced or being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting.
Detailed Description of the Invention The invention pertains to genetically down regulating a lignin pathway 4coumarate Co-enzyme A ligase (4CL) in a plant Plants which have been genetically transformed to down regulate 4CL will hereafter be called transgenic plants. Such down regulation can result in faster growing plants. Such down regulation can also result in a reduction in the lignin content of the plants and/or altered lignin structure. Such down regulation can further result in increased cellulose content. Such down regulation may also result in increased disease resistance. Further, by using a specific 4CL promoter, targeted tissue-specific gene expression can be achieved in either the xylem or the epidermal tissues of the plant.
A. 4CL Lignin is synthesized by the oxidative coupling of three monolignols (coumaryl, coniferyl and sinapyl alcohols) formed via the phenylpropanoid pathway as shown in Fig. 1. Reactions in the phenylpropanoid pathway include the deamination of phenylalanine to cinnamic acid followed by hydroxylations, methylations and activation of substituted cinnamic acids to coenzyme A (CoA) esters. The CoA esters are then reduced to form monolignols which are secreted from cells to form lignin.
The products of the phenylpropanoid pathway are not only required for the synthesis oflignin but also required for the synthesis of a wide range of aromatic compounds including flavonoids, phytoalexins, stilbenes and suberin.
In the phenylpropanoid pathway, 4CL activates a number ofcinnamic acid derivatives, including 4-coumaric acid, caffeic acid, ferulic acid, hydroxyferulic acid and sinapic acid. The resulting products, CoA esters, serve as substrates for entry into various branch pathways, such as lignin, flavonoids, phytoalexins, stilbenes and suberin. The esterification reactions catalyzed by 4CL require high energy and the reactions are not likely to occur without 4CL.
4CL is important in making a continuous flow of the lignin biosynthesis pathway. 4CL is also important because it is located at the branching points of the phenylpropanoid metabolism. 4CL is suggested to play a pivotal role in regulating carbon flow into specific branch pathways of the phenylpropanoid metabolism in response to stages of development and environmental stress.
The basic properties of 4CL are quite uniform. 4CL depends on ATP as a cosubstrate and requires Mg" as a cofactor. The optimal pH for 4CL ranges from pH 7.0 to 8.5 and the molecular weight of 4CL isoforms from various plant species ranges from 40 kD to 75 kD. Most 4CLs have high affinity for substituted cinnamic acids. 4CL has the highest activity with 4-coumaric acid.
4CL cDNA sequences have been reported for parsley, potato, soybean, rice, loblolly pine, Arabidopsis, Lithosperum, Vanilla and tobacco. 4CL genes have been isolated and sequenced for parsley, rice, potato and loblolly pine. The analysis of 4CL cDNAs and genes indicates that 4CL is encoded by multiple/divergent genes in rice, soybean, and Lithosperum, very similar genes in parsley, potato, tobacco, and loblolly pine, and a single gene in Arabidopsis.
Two similar 4CL cDNAs in parsley, potato and tobacco have been shown to be expressed at similar level in response to environmental stress and during different developmental stages. Two distinct 4CL cDNAs in soybean and Lithosperum have shown different expression levels when pathogens or chemicals were applied to the cell cultures. It appears that the expression of the 4CL genes is developmentally regulated and inducible by many environmental stresses at the transcription level. 4CL promoters have been isolated and sequenced for parsley, rice and potato.
Alignment of deduced amino acid sequences of cloned plant 4CL sequences reveals two highly conserved regions. The first conserved region (LPYSSGTTGLPK; SEQ ID NO:7), proposed to designate a putative AMPbinding region, consists of a serine/theronine/glycine-rich domain followed by a proline/lysine glycine triplet. The second conserved region (GEICIRG; SEQ ID NO:8) contains one common Cys residue. The amino acid sequences of 4CL from plants contain a total of five conserved Cys residues.
The description of the invention hereafter refers to the tree species aspen, and in particular quaking aspen (Populus tremuloides Michx), when necessary for the sake of example. However, it should be noted that the invention is not limited to genetic transformation of trees such as aspen. The method of the present invention is capable of being practiced for other plant species, including for example, other angiosperm, and other gymnosperm forest plants species, legumes, grasses, other forage crops and the like.
Preferably, the 4CL down regulation is accomplished through transformation with a homologous 4CL sequence in an antisense orientation.
However, it should be noted that a heterologous antisense 4CL sequence could be utilized and incorporated into a plant species to down regulate 4CL if the heterologous 4CL gene sequence has a high nucleotide sequence homology or identity of at least about 70%, more preferably at least about 80%,;:and more preferably at least about 90%, to the endogenous (native) 4CL gene sequence of that plant species, a tree species.
In addition, plants transformed with a sense 4CL sequence may also cause a sequence homology-based cosuppression of the expression of the transgene and endogenous 4CL gene, thereby achieving down regulation of 4CL in these plants.
B. Isolation of 4CL cDNAs The present invention utilizes a homologous 4CL sequence to genetically alter plants. The example described below utilizes a cDNA clone of the quaking aspen 4CL gene to genetically alter quaking aspen.
Two 4CL cDNAs, Pt4CL1 and Pt4CL2, have been isolated from quaking aspen. Pt4CLI cDNA is lignin pathway-specific and is different from Pt4CL2 cDNA, which is involved in flavonoid synthesis. It should be noted that the methods described below are set forth as an example and should not be considered limiting. The sequences of these 4CL cDNA clones are available from Genbank, Accession Nos. AF041049 and AF041050.
Pt4CLI and Pt4CL2 genomic clones including their 5' -end regulatory promoter sequences were also isolated. The promotor ofPt4CL 1 (Pt4CLlp) directs xylem tissue-specific gene expression in a plant, whereas the promoter of Pt4CL2 (Pt4CL2p) drives the expression of genes specifically in epidermal tissues of stem and leaf of a plant. These tissue specific promoters will be discussed in more length below.
Young leaves and shoot tips are collected from greenhouse-grown quaking aspen (Populus tremuloides Michx). Differentiating xylem is collected from three to four year old quaking aspen. The bark is peeled from the tree exposing the developing secondary xylem on the woody stem. Developing secondary xylem is scraped from the stem and bark with a razor blade and immediately frozen in liquid nitrogen until use.
Total RNA is isolated from the young leaves, shoot tips, and xylem following the method of Bugos et al., Biotechniques 19(5):734-737 (1995).
Poly(A)+ RNA is purified from total RNA using Poly(A) mRNA Isolation Kit from Tel-test B, Inc. A unidirectional Lambda gt22 expression cDNA library was constructed from the xylem mRNA using Superscript X System from Life Technologies, Inc. and Gigapack Packaging Extracts from Stratagene. The Pt4CL1 cDNA was obtained by screening the cDNA library with a 32 P-labeled parsley 4CL cDNA probe. The parsley 4CL cDNA (pc4CL2) has Genbank Accession No. X13325.
The Pt4CL2 cDNA was obtained by RT-PCR. The reverse transcription of total RNA isolated form shoot tips was carried out using the Superscript II reverse transcriptase from Life Technologies. Two sense primers (R S, TTGGATCCGGIACIACIGGIYTICCIAARGG-3'; SEQ ID NO:9 and HIS, TTGGATCCGTIGCICARCARGTIGAYGG-3'; SEQ ID NO:10) were designed around the first consensus AMP-binding region of 4CL that was previously discussed. One antisense primer (R2A, ATGTCGACCICKDATRCADATYTCICC-3'; SEQ ID NO:11) was designed based on the sequence of the putative catalytic motif GEICIRG (SEQ ID NO: 12).
One fifth of the reverse transcription reaction (4 il) is used as the template in a il PCR reaction containing IX reaction buffer, 200 lM each deoxyribonucleotide triphosphate, 2 pM each RIS and oligo-dT (20 mer) primers, and 2.5 units of Taq DNA polymerase. The PCR reaction mixture was denatured at 94°C for 5 minutes followed by 30 cycles of94°C/45 seconds, 50°C/1 minute, 72 0 C/90 seconds and is ended with a 5 minute extension at 72 0 C. 2 pl of the PCR amplification products were used for a second run PCR re-amplification using primers HIS and R2A. A 0.6 kb PCR fragment was cloned using the TA Cloning Kit from Invitrogen and used as a probe to screen an aspen genomic library to obtain the Pt4CL2 genomic clone. Two primers (2A, 5'-TCTGTCTAGATGATGTCGTGGCCACGG-3'; SEQ ID NO:13 and 2B, 5'-TTAGATCTCTAGGACATTGGTGT GC-3'; SEQ ID NO:14) were designed based on the genomic sequence of Pt4CL2 around the deduced transcription start site and the stop codon. These primers were used to clone Pt4CL2 cDNA by RT-PCR, as described above using total RNA isolated from shoot tips.
The DNA sequences of Pt4CLI and Pt4CL2 cDNA were determined using a Taq Cycle Sequencing kit from Amersham.
The Pt4CL1 cDNA has an open reading frame of 1605 bp which encodes a polypeptide of 535 amino acid residues with a predicted molecular weight of 58.498 kd and pi of 5.9. The nucleotide sequence of the aspen 4CL cDNA clone Pt4CL1 is set forth as SEQ ID NO:1. The deduced amino acid sequence for the aspen 4CL1 protein is set forth as SEQ ID NO:2.
The Pt4CL2 cDNA has an open reading frame of 1710 bp which encodes a polypeptide of 570 amino acid residues with a predicted molecular weight of 61.8 kd and pi of 5.1. The nucleotide sequence of the aspen 4CL cDNA clone Pt4CL2 is set forth as SEQ ID NO:3. The deduced amino acid sequence for the aspen 4CL2 protein is set forth as SEQ ID NO:4.
13 The aspen Pt4CLI cDNA shares a 55-69% identity at the nucleotide level and 57-76% identity at the amino acid level with previously reported 4CL cDNAs and genes, whereas the Pt4CL2 cDNA shares a 60-71% identity at the nucleotide level and 58-73% at the amino acid level with other 4CL cDNAs and genes as set forth in the following table.
Table 1: Cornparison of Pt4CL1 and Pt4CL2 nucleotide and predicted amino add seq ences to each other and other full length 4CL senuences.
Comparison with Pt4CLI Comparison with Pt4CL2 Gene DNA Identity Protein Identity Protein Similarity DNA Identity Protein Identity Protein Similarity Pt4CLl 61-3 63.4 72.7 Pt4CL2 61.3 63.4 72.7 Le4CL1 64.5 70.7 78.1 61.8 64.6 73.4 Le4CL2 60.1 57.3 67.7 71.1 73 77.5 Nt4CL1 66 74.8 83.1 61.5 65.3 74.4 Nt4CL2 64.1 75 82.9 62.1 6-6.8 76 Os4CLI 59.2* 59.8 70.2 59.6* 57.7 69.5 Os4CL2 54.9 57.7 67.3 63.9 66.5 73.8 Pc4CLl 65.1 71.2 79.6 62 64.3 73.5 Pc4CL2 65 71.4 79.6 62.9 64.5 73.5 Ptd4CLI 66.6 73.7 82.2 64.5 66.6 75.8 Ptd4CL2 67 74.2 81 63.4 64.7 73.3 At4CL 63.7 69.9 78.7 62.4 61.1 70.2 Lp4CL 60.1 64 73.9 62.3 67.9 77.8 St4CLI 69.1* 74 81.4 62.2* 65.3 74.5 Vp4CL 65.2 75.5' 81.6 161.5 66.5 74.1 Pt4CL I and Pt4CLW: aspen 4CL Le4CL1 and Le4CL2: lithospermum erythrorhizon 4CL Nt4CLI and Nt4CL2: tobacco 4CL OS4CLI and Os4CL2: rice 4CL (*.DNA sequence'compared to Os4CLI PC4CL I and Pc4CL2: Parsley 4CL Ptd4CL I and Ptd4CL2: hybrid poplar 4CL At4CL: Arab idopsis 4CL Lp4CL: lobolly pine 4CL St4CL potato 4CL (*.DNA sequence compared to coding region only) Vp4CL: vanilla 4CL coding region only) In a study to characterize lignification in aspen stems, it was observed that the lignin composition in the top four interodes (referred to as top internodes hereafter) was different from that in the fifth and subsequent internodes, suggesting the involvement of developmentally regulated differential expression of lignin pathway genes during the transition from primary to secondary growth in aspen stem. To investigate whether this transition regulates differential expression of 4CL gene members, 4CL genes were cloned from top and lower (6t-10 t intemodes and secondary-developing xylem tissue of aspen stems. Nucleotide sequence analysis revealed that clones derived from lower internodes were identical to Pt4CL1, whereas clones isolated from top internodes could be divided into two groups (TI and T2). Clones in Group T1 were found identical to Pt4CL1. Clones in group T2 shared 60-75% sequence homology with other plant 4CL genes but were distinct from Pt4CLl cDNA and designated as Pt4CL2-600. These results together with Northern hybridization analysis suggested that Pt4CL2-600 represents a fragment of another aspen 4CL gene expressed in top internodes.
The results of sequence analysis, phylogenetic tree and genomic Southern blot analysis indicate that Pt4CL1 and Pt4CL2 cDNAs encode two distinct 4CLs that belong to two divergent gene families in aspen. The deduced amino acid sequence for the Pt4CL2 protein contains a longer N-terminal sequence than the Pt4CLI protein but shows profound similarity in the central and C-terminal portions of protein to the Pt4CL1 protein.
Pt4CL1 and Pt4CL2 cDNAs display distinct tissue-specific expression patterns. The Pt4CL1 sequence is expressed highly in the secondary developing xylem and in the 6th to 10th intemodes whereas the Pt4CL2 sequence is expressed in the shoot tip and leaves. These tissue-specific expression patterns were further investigated by fusing promoters of Pt4CLl and Pt4CL2 genes to a GUS reporter gene. The tissue specific promoters for Pt4CL1 and Pt4CL2 are discussed in more length below.
The substrate specificity of Pt4CLl and Pt4CL2 is also different from each other as determined using recombinant proteins produced in E. coli.
Pt4CLI utilized 4-coumaric acid, caffeic acid, ferulic acid and acid as substrates. Pt4CL2 showed activity for 4-coumaric acid, caffeic acid and ferulic acid but not to 5-hydroxyferulic acid.
Specifically, Pt4CLI and Pt4CL2 were used to construct expression vectors for E coli expression. The substrate specificity of Pt4CLl and Pt4CL2 was tested using fusion proteins produced in E. coli. Two plasmids, pQE/4CL and pQE/4CL2, were constructed in which the coding regions of Pt4CL1 and Pt4CL2, respectively, were fused to N-terminal His tags in expression plasmids pQE-31 and pQE-32 (QIAGEN, Chatsworth, CA). The recombinant proteins of Pt4CLl and Pt4CL2 produced by E. coli were approximately 60 kD and 63 kD, respectively.
The two recombinant proteins were tested for their activity in utilizing cinnamic acid derivatives. Pt4CL1 recombinant protein showed 100, 51, 72, 19 and 0% relative activity to 4-coumaric acid, caffeic acid, ferulic acid, hydroxyferulic acid and sinapic acid, respectively. Pt4CL2 recombinant protein exhibited 100, 31, 26, 0 and 0% relative activity to 4-coumaric acid, caffeic acid, ferulic acid, 5-hydroxyferulic acid and sinapic acid, respectively. Neither recombinant protein showed detectable activity to sinapic acid.
The results of the tissue-specific expression pattern and substrate specificity suggests that in addition to the general function of4CL, Pt4CLl apparently is more related to lignin synthesis in the xylem tissue and Pt4CL2 apparently is more likely involved in flavonoid synthesis and UV protection.
It should be noted that the isolation and characterization of the Pt4CLl and Pt4CL2 cDNA clones is described in Kawaoka et al., Proceedings of the 6th International Conference on Biotechnology in the Pulp and Paper Industry, Vienna, Austria (1995); and in Hu, Wen-Jing, Isolation and Characterization of 4-coumarate: Coenzyme A Ligase cDNAs and Genes from Quaking Aspen (Populus tremuloides Michx), Ph.D. Dissertation, Michigan Technological University, Houghton, Michigan (1997); and Tsai et al., Plant Physiol., 117, 101 (1998).
C. Transformation and Regeneration Several methods for gene transformation of plant species with the 4CL sequence are available such as the use ofAgrobacterium, electroporation, particle bombardment with a gene gun or microinjection.
Preferably, a 4CL cDNA clone is positioned in a binary expression vector in an antisense orientation under the control of double cauliflower mosaic virus 35S promoter. The vector is then preferably mobilized into a strain of Agrobacterium species such as tumefaciens strain C58/pMP90 and is used as the DNA delivery system due to its efficiency and low cost.
For example, with reference to Fig. 2, the binary expression pA4CLI used for plant transformations is shown. Specifically, the Pt4CL1 cDNA is inserted in an antisense orientation into Pac I and BamH I sites between the double CaMV 35S/AMV RNA4 and the 3' terminator sequence of the nopaline synthase gene in a binary cloning vector pA4CL1 (Fig. The binary vector containing hygromycin phosphotransferase (HPT) gene is modified from pBin 19. The gene construct pA4CLI is available from Michigan Technological University, Institute of Wood Research, Houghton, Michigan.
The binary vector construct is mobilized into Agrobacterium tumefaciens using the freeze-thaw method of Holsters et al., Mol. Gen. Genet. 163: 181-187 (1978). For the freeze-thaw method, 1.5 ml of overnight cultures Agrobacterium tumefaciens strain C58/pMP90 is pelleted at 5000 x g for 3 minutes at 4 0 C and suspended in 1 ml of ice cold 20 mM CaCI,. To the suspension is added 10 pl binary vector DNA (from an alkaline lysis minipreparation) and mixed by pipetting. The microcentrifuge tube is then frozen in liquid nitrogen for minutes and thawed at 37C for 5 minutes. After being cooled on ice, 1 ml of LB is added and the mixture is incubated at 28 0 C for 2 hours with gentle shaking. 200 pl of the cells is spread onto LB plates containing gentamycin and kanamycin and incubated at 28 °C for 2 days. Colonies grown on the selection plates are randomly picked or miniprep and restriction enzyme digestion analysis is used to verify the integration.
The resulting binary vector containing Agrobacterium strain is used to transform quaking aspen according to Tsai et al., Plant Cell Rep. 14: 94-97 as set forth below.
Explants of young leaves from cuttings of aspen are obtained by cutting leaf disks of approximately 7 mm square from the young leaves along the midrib of the leaves. The explants are surface sterilized in 20% commercial bleach for minutes followed by rinsing 3 times with sterile distilled, deionized water.
All of the culture media used includes the basal medium of woody plant medium (WPM) as described in Lloyd et al., Proc. Int. Plant Prop. Soc. 30: 421- 437 (1980) and supplemented with 2% sucrose. 650 mg/L calcium gluconate and 500 mg/L MES are added as pH buffers as described in Tsai et al., Plant Cell Reports, 1994. All culture media is adjusted to pH 5.5 prior to the addition of 0.75% Difco Bacto Agar and then autoclaved at 121 °C and 15 psi for minutes. Filter sterilized antibiotics are added to all culture media after autoclaving. All culture media are maintained at 23 1 °C in a growth chamber with 16 hour photoperiods (160 uE x m 2 x except for callus induction (as will be described later) which is maintained in the dark.
The sterilized explants are then inoculated with the mobilized vector with an overnight-grown agrobacterial suspension containing 20 tM acetosyringone.
After cocultivation for 2 days, the explants are washed in 1 mg/ml claforan and ticarcillin for 2 hours with shaking to kill Agrobacterium. The explants are blotted dry with sterile Whatman No. 1 filter paper and transferred onto callus induction medium containing 50 mg/L kanamycin and 300 mg/L claforan to induce and select transformed callus. The callus induction medium is the basal medium with the addition of 6-benzyladenine (BA) and 2, 4dichlorophenoxyacetic acid 4-D) at concentrations of 0.5 mg/L and 1 mg/L, respectively, to induce callus.
The kanamycin-resistant explants are then subcultured on fresh callus induction media every two weeks. Callus formation occurs after approximately four weeks. Formed calli are separated from the explant and subcultured periodically for further proliferation.
When the callus clumps reach approximately 3 mm in diameter, the callus clumps are transferred to shoot regeneration medium. The shoot regeneration medium is the basal medium containing 50 mg/L kanamycin, mg/L thidiazuron (TDZ) as a plant growth regulator and claforan at 300 mg/L to kill Agrobacterium. Shoots were regenerated about 4 weeks after callus is transferred to regeneration medium.
As soon as the shoots are regenerated, they are immediately transferred to hormone-free elongation medium containing 50 mg/L kanamycin and, whenever necessary, claforan (300 mg/L), to promote elongation. Green and healthy shoots elongated to 2-3 cm in length are excised and planted separately in a hormone-free rooting medium containing 50 mg/L kanamycin. The efficient uptake of kanamycin by shoots during their rooting stage provides the most effective selection for positive transformants. Transgenic plants are then transplanted into soil medium of vermiculite:peatmoss:perlite at 1:1:1 and grown in the greenhouse.
The above described transformation and regeneration protocol is readily adaptable to other plant species. Other published transformation and regeneration protocols for plant species include Danekar et al., Bio/Technology 5:587-590 (1987); McGranahan et al., Bio/Technology 6:800-804 (1988); McGranahan et al., Plant Cell Reports 8:512-616 (1990); Chen, Ph.D. Thesis, North Carolina State University, Raleigh, North Carolina (1991); Sullivan et al., Plant Cell Reports 12:303-306 (1993); Huang et al., In Vitro Cell Dev. Bio.
4:201-207 (1991); Wilde et al., Plant Physiol. 98:114-120 (1992); Minocha et al., 1986 Proc. TAPPI Research and Development Conference, TAPPI Press, Atlanta, pp. 89-91 (1986); Parsons et al., Bio/Technology 4:533-536 (1986); Fillatti et al., Mol. Gen. Genet 206:192-199 (1987); Pythoud et al., Bio/Technology 5:1323-1327 (1987); De Block, Plant Physiol. 93:1110-1116 (1990); Brasileiro et al., Plant Mol. Bio 17:441-452 (1991); Brasileiro et al., Transgenic Res. 1:133-141 (1992); Howe et al., Woody Plant Biotech., Plenum Press, New York, pp. 283-294 (1991); Klopfenstein et al., Can. J. For. Res.
21:1321-1328 (1991); Leple et al., Plant Cell Reports 11:137-141 (1992); and Nilsson et al., Transgenic Res. 1:209-220 (1992).
D. Phenotype Changes The results of the transformation can be confirmed with conventional PCR and Southern analysis. Transferring 4CL cDNA in an antisense orientation down regulates 4CL in the plant. Expression of the 4CL has been found to be blocked up to 96 percent of 4CL enzyme activity in some transgenic plants.
In the aspen example, after acclimation, the transgenic aspen displayed an unusual phenotype, including big curly leaves, thick stem diameter, longer internodes, more young leaves in the shoot tip and a red pigmentation in the petioles extending into midvein leaves. Red coloration of the developing secondary xylem tissues is observed after peeling of the bark in the transgenic plants.
E. Accelerated Growth Down regulation of 4CL altered growth of the transgenic plants. For example, transformation with an antisense 4CL sequence accelerated the growth of the plant. Enhanced growth is markedly noticeable at all ages. In particular the transgenic trees showed enhanced growth in the form of thicker stems and enlarged leaves as compared to control plants. These characteristics are retained in the vegetative propagules of these transgenic trees. Table 2 sets forth exemplary data with respect to several lines of transgenic quaking aspen grown in the greenhouse after eight months. Volume represents the overall quantitative growth of the plant.
Table 2: Growth Measurement for Control and Transgenic Plants Plant Height Diameter Volume Average Length of (cm) (cm 3 Intemode (cm) Control 1 247.7 1.08 75.6 2.6 Control 2 250.2 1.01 66.8 2.8 11-1 304.8 1.15 105.5 3.1 11-2 248.9 1.01 66.4 3.4 11-3 241.3 0.84 44.6 3.2 11-4 288.3 0.94 66.7 3.4 11-5 246.4 0.92 54.6 3.3 11-7 226.7 1.13 75.7 3.4 11-8 289.6 1.16 102.0 3.3 11-9 287.0 1.76 232.6 4.3 11-10 252.7 0.83 45.6 3.1 11-11 247.7 0.86 48.0 12-1 247.7 1.1 78.4 2.7 12-2 199.4 0.96 48.1 12-6 294.6 0.92 65.2 3.2 16-1 227.3 0.95 53.7 2.8 16-2 278.1 0.97 68.5 3.4 16-3 265.4 1.09 82.5 17-2 243.8 0.89 50.5 2.6 at 10 cm above ground The averages for height, diameter, volume and average length between internodes for the control plants are as follows: Height (cm) 248.95 Diameter (cm) 1.045 Volume (cm 3 71.2 Ave. Length of Internodes (cm) 2.7 With respect to height alone, for those transgenic plants (11-1, 11-4, 11- 8, 11-9, 12-6, 16-2, 16-3) having a statistically larger height than the control plants, the average height was 286.83 cm as compared to the control plant average height of 248.95 cm.
With respect to diameter alone, for those transgenic plants (11-1, 11-7, 11-8, 11-9) having a statistically larger diameter than the control plants, the average diameter was 1.30 cm as compared to the control plant average diameter of 1.045 cm.
With respect to volume alone, for those transgenic plants (11-1, 11-8, 11- 9, 12-1, 16-3) having a statistically larger volume than the control plants, the average volume was 120.2 cm 3 as compared to the control plant average volume of 71.2 cm 3 With respect to average length of internodes alone, for those transgenic plants (11-1, 11-2, 11-3, 11-4, 11-5, 11-7, 11-8, 11-9, 11-10, 12-6, 16-2, 16-3) having a statistically larger average length ofintemodes than the control plants, the average length of intemodes was 3.39 cm as compared to the control plant average length of interodes of 2.7_ cm.
As demonstrated in Table 2, while there are variations in growth among the transgenic plants, the average length of the internodes for the transgenic plants is consistently and significantly higher than that of the control plants.
Moreover, there is also faster root initiation, and alterations, an increase, in root fresh weight and length, enhanced root growth. Variations in the growth of the transgenic plants is normal and to be expected. Preferably, a transgenic plant with a particular growth rate is selected and this plant is vegetatively propagated to produce an unlimited number of clones that all exhibit the identical growth rate.
F. Lignin Down regulation of lignin pathway 4CL results in production of plants with reduced lignin content.
The following table shows the reduction of lignin content and 4CL enzyme activity in several transgenic aspen which were transformed with a homologous antisense 4CL sequence.
Table 3: Characterization of Transgenic Aspen Plants Harboring Antisense 4CL Sequence Transgenic Lignin Content Lignin %4CL 4CL Enzyme Plant Based on Reduction Enzyme Activity Wood Weight Activity* Reduction Control 21.4 0.0 868 0 11-1 20.5 4.2 1171 11-2 19.2 10.3 515 11-3 20.9 2.3 922 6 11-4 19.7 7.9 1032 -19 11-5 19.7 7.9 691 11-7 19.9 7.0 578 38 11-8 20.2 5.6 694 11-9 20.4 4.7 806 14 11-10 19.4 9.3 455 51 11-11 20.4 4.7 726 22 12-1 12.8 40.2 49 12-2 12.6 41.1 62 93 12-3 11.9 44.4 61 94 12-6 19.8 7.5 786 16 16-1 12.8 40.2 35 96 16-2 20.6 3.7 780 17 16-3 21.0 1.9 795 17-1 20.5 4.2 855 9 17-2 21.4 0.0 925 1 *activity is expressed as pkat/(mg protein) using 4-coumaric acid as the substrate Lignin content was determined according to Chiang and Funaoka (1990) Holzforschung 44:147-155. 4CL enzyme activity was determined according to Ranjeva et al. (1976), Biochimie 58:1255-1262.
The data in Table 3 demonstrates a correlation between down regulation of 4CL and reduction in lignin content. Transgenic plants with reduced lignin content have an altered phenotype in that the stem is more elastic to the touch or less curly.
It should also be noted that for those transgenic plants (12-1, 12-2, 12-3 and 16-1) with the approximately 40% reduction in lignin content and the corresponding approximately 95% reduction in 4CL enzyme levels, all of those transgenic plants had a consistent deep red coloration in the wood of the plant.
Accordingly, the deep red color can be used as an identifier of reduced lignin content.
Down regulation of lignin pathway 4CL can also result in production of plants with an altered lignin structure. Based upon thioacidolysis (Rolando et al.
(1992) Thioacidolysis, Methods in Lignin Chemistry, Springer-Verlag, Berlin, pp. 334-349) of plants 12-3 and 16-1, coniferyl alcohol and sinapyl alcohol lignin units are significantly reduced in these two plants as compared to the control tree, as shown in the following table.
Table 4: Altered Lignin Structure Plant Coniferyl Alcohol Units Sinapyl Alcohol Units* Control 733 1700 12-3 283 592 16-1 247 445 *micro-mole/g of lignin The alteration of the frequency of the structural units in lignin of these .transgenic plants is evidence that the overall structure of lignin in these plants has been genetically altered.
G. Cellulose Content Down regulation of lignin pathway 4CL can result in increased cellulose content of the transgenic plants. Analysis of control and transgenic aspen for carbohydrate content demonstrate a higher cellulose content in the transgenic plants than the control plants. Particularly, the transgenic plants that have over lignin reduction have about 10-15% higher cellulose content than the control. Data is set forth in the following tables for trees that were transformed with homologous 4CL in an antisense orientation: Table 5: Analysis of Carbohydrate Components in Transgenic and Control Aspen Plant Glucan Arabinan Galactan Rhamnan Xylan Mannan Control 44.23% 0.47% 0.79% 0.37% 17.19% 1.91% 11-2 49.05% 0.36% 1.05% 0.38% 15.34% 2.04% 11-9 45.95% 0.40% 0.80% 0.37% 17.12% 1.83% 11-10 47.49% 0.43% 0.99% 0.40% 16.24% 2.35% 12-3 50.83% 0.55% 1.24% 0.48% 17.25% 1.77% 16-1 48.14% 0.56% 1.07% 0.48% 19.14% 1.58% 16-2 46.55% 0.34% 0.82% 0.37% 16.75% 2.31% Table 6: Comparison of Lignin and Cellulose (glucan) Contents in Transgenic and Control Aspen Plant Lignin Cellulose Content Reduction Content Increase on Wood on Wood Control 21.4 0 44.23 0 11-2 19.2 10.3 49.05 10.9 11-9 20.4 4.7 45.95 3.9 11-10 19.4 9.3 47.49 7.4 12-3 11.9 44.5 50.83 14.9 16-1 12.8 40.2 48.14 8.8 16-2 20.6 3.7 46.55 5.2 11-6 18.6 13.1 45.98 3.8 12-1 12.5 40.2 48.35 9.3 12-2 12.6 41.1 49.74 12.5 12-5 14.4 32.7 45.58 3.1 The procedure for carbohydrate analysis utilized is as follows. About 100 mg of milled woody tissue powder with sizes that pass a 80-mesh screen was hydrolyzed with I mL of 72% H2S04 for 1 hr at 30 0 C. Samples were then diluted to 4% H2S04 with distilled water, fucose was added as an internal standard, and a secondary hydrolysis was performed for 1 hr at 121 After secondary hydrolysis, the sugar contents of the hydrolysates are determined by anion exchange high performance liquid chromatography using pulsed amperometric detection. Sugar contents are expressed as of the weight of the woody tissue used. The above procedures are similar to those in a publication by Pettersen and Schwandt, J. Wood Chem Technol. 11:495-501 (1991).
H. Increased Disease Resistance Down regulation of lignin pathway 4CL can result in altered levels of phenylpropanoids or secondary metabolities that display antimicrobial activity.
Thus, transgenic plants with down-regulated 4CL can result in enhanced disease resistance, and in particular, with increased fungal pathogen resistance. In particular, greenhouse transgenic aspen plants may show a disease resistance to fungi such as those which induce leaf-blight disease.
I. Promoters Two distinct genes encoding 4CL and their promoters were cloned. The promoter of Pt4CL1 can drive gene expression specifically in xylem tissue and the promoter for Pt4CL2 confers gene expression exclusively in the epidermal tissues. These promoters can be used to manipulate gene expression to engineer traits of interest in specific tissues of target plants. The significance of the promoters is the application of the xylem-specific promoter to direct the expression of any relevant genes specifically in the xylem for engineering lignin content, lignin structure, enhanced growth, cellulose content, other value-added wood qualities, and the like. The importance of the epidermis-specific promoter is its ability to drive the expression of any relevant genes specifically in epidermal tissues for engineering disease-, UV light-, cold-, heat-, drought-, and other stress resistance traits in plants.
Specifically, the promoters of the Pt4CLI and Pt4CL2 were isolated as follows. An aspen genomic library was screened with Pt4CLI cDNA and Pt4CL2 partial cDNA fragment to isolate genomic clones of Pt4CL1 and Pt4CL2. Eleven and seven positive genomic clones were identified for Pt4CLl and Pt4CL2 gene; respectively. Among 11 positive clones for Pt4CL1, Pt4CL1g-4 contained a full length coding sequence and at least 2 kb of flanking regions. The restriction map of Pt4CLlg-4 is set forth at Fig. 3.
With respect to Pt4CL2, restriction map analysis was performed on XDNA of positive genomic clone Pt4CL2g-11 which contains a full length coding sequence and about 1.2 kb of 5' flanking region. The restriction map of Pt4CL2g- 1 is set forth at Fig. 4.
Approximately a 2.3 kb 5' flanking region of Pt4CL1 was digested from Pt4CL1g-4 using Xba I and Sac I sites and cloned into pGEM7Z Xba I and Sac I sites. The subcloned Pt4CLl promoter was named p7Z-4XS and the restriction map of P7Z-4XS is set forth at Fig 5. The 5' unilateral deletion of p7Z-4XS was generated for DNA sequencing by exonuclease Il/S nuclease digestion using Erase-a-Base System (Promega, Madison, WI). The deletion series was sequenced using a primer on pGEM7Z vector.
A 1.5 kb Hind IlI and EcoR I fragment containing a 1.2 kb 5' flanking region of Pt4CL2 and 0.3 kb coding region of Pt4CL2g-11 was subcloned in pBluescript II SK+ Hind I and EcoR I sites. The restriction map of the resulting clone, pSK-11HE, was determined by digesting the plasmid with several restriction enzymes, as in set forth at Fig. 6. In order to determine the sequence of the Pt4CL2 promoter, pSK-11HE was further digested into small fragments according to the restriction map and subcloned into vectors with suitable cloning sites. The DNA sequence was determined using M13 universal primer and reverse primer on the vector.
The DNA sequences of the two promoters was determined and analyzed using ATaq cycle sequencing Kit (USB, Cleveland, OH), and GENETYX-MAC 7.3 sequence analysis software from Software Development Co., Ltd. The nucleotide sequence of promoter region of Pt4CL1 is set forth as SEQ ID and the nucleotide sequence of the promoter region of Pt4CL2 is set forth as SEQ ID NO:6. The sequence of the promoter regions of Pt4CLlp and Pt4CL2p is available from Genbank, Accession Nos. AF041051 and AF041052, respectively.
The insignificant sequence similarity between the and 3'-noncoding regions of these two genes and their distinct exon-intron organizations (four introns in Pt4CL1 and five in Pt4CL2) further substantiate their functional and perhaps evolutionary divergency. Striking differences also were observed in the promoter sequences of these two genes. Three cis-acting elements, box P (CCTTTCACCAACCCCC; SEQ ID NO:15), box A (CCGTTC; SEQ ID NO:16), and box L (TCTCACCAACC; SEQ ID NO: 17), previously shown to be consensus in all known plant phenylalanine ammonialyase (PAL) and 4CL gene promoters (Hahlbrook et al., Proc. Natl. Acad. Sci. USA, 92, 4150 (1995); Logemann et al., Proc. Natl. Acad. Sci. USA, 92, 5905 (1995)), were identified within the Ikb 5' flanking sequence of Pt4CLI (GenBank Accession No.
AF041051). However, none of these boxes could be found within the analyzed 1.2 kb 5' flanking region of Pt4CL2 (GenBank Accession No. AF041052), suggesting that promoter differences between Pt4CL and Pt4CL2 genes could be responsible for the strikingly different patterns of tissue-specific expression of these genes, as observed in Northern analysis.
Tissue-specific expression can be achieved by fusing the promoters of Pt4CL1 or Pt4CL2 to a gene, an open reading frame of interest and transferred to a plant species via Agrobacterium. For the sake of example, the promoters of Pt4CL1 and Pt4CL2 were fused to a GUS reporter gene as detailed below. However, it should be noted that genes other than the GUS reporter gene can be fused to these promoters for tissue specific expression.
In order to construct Pt4CL1 promoter-GUS binary vector, a 1 kb fragment covering 5'-flanking region and 17 bp coding region of Pt4CL1 was subcloned into pGEM7Z Sph I and EcoR I sites for constructing promoter-GUS binary vector. In this 1 kb DNA fragment, it is found that one Xho I site is located at 486 bases upstream to the translation start site and the EcoR I site is located at 17 bases downstream the translation start site. This 0.6 kb fragment was subcloned into pGEM7ZXho I and EcoR I sites and used as a template in PCR amplification.
In order to construct a promoter-GUS transcriptional fusion, a BamH I site was introduced in front of the translation start site of Pt4CL by PCR. PCR amplification was performed using p7Z-4XE as the template, M13 universal primer on pGEM7Z vector as 5' end primer and Pt4CLlp-1 primer containing a BamH I site at the end is complementary to a sequence upstream of the translation start site. The reaction was carried out in 100 pl reaction mix containing lx pfu reaction buffer, 200 pl each dNTPs, 100 uiM each primer and units ofpfu. The PCR reaction mixture was denatured at 94 °C for 5 minutes followed by 30 cycles of 94°C (1 minute), 55 0 C (1 minute), 72 0 C (1 minute, seconds) and was ended with a 5 minute extension at 72 0
C.
The amplified 0.6 kb fragment was cloned and sequenced to confirm the sequence. The engineered 0.6 kb fragment was ligated to p7Z-4SE which was digested with Xho I and BamH I. In order to incorporate a Hind I site in the end of Pt4CL1 promoter, the I kb Sph I-BamH I PtCCLl promoter region was the cloned into pNoTA (5 prime 3 prime Inc., Boulder, CO) Sph I and BamH I site. The 1 kb Pt4CLl promoter was then released from pNoTA vector with Hind III and BamH digestion and subsequently transcriptionally fused to pBIl01 Hind II and BamH I sites in front of GUS. The resulting binary vector was named Pt4CLlp-GUS and is set forth at Fig. 7.
In order to construct Pt4CL2 promoter-GUS binary vector, pSK-11 HE was digested with Sph I and EcoR I to release 0.2 kb Sph I and EcoR I fragment.
The 0.2 kb fragment was cloned into pGEM7Z Sph I and EcoR I sites. A primer, Pt4CL2p-3' (5'-CATCGGATCCTGAGATGGAAGGGAGTTTCT-3'; SEQ ID NO: 15) was designed to be complementary to a sequence upstream of the translation start site of Pt4CL2 and to incorporate BamH I site at the end.
Amplification was performed using p7Z 1SE as a template, M13 universal primer as the 5' end primer and Pt4CL2p-3 as the 3' end primer. A PCR reaction was carried out and the amplified PCR product was cloned and sequenced to check the fidelity of the PCR amplification. The 0.2 kb Sph I- BamH I DNA fragment with correct sequence was fused to pSK-11HE linearized with Sph I and BamH I. The resulting plasmid was named pSK-11HB. The promoter of PtCCL2 was then excised from pSK-11HB with Hind II and BamH I and ligated to PBI101 and Hind III and BamH I site to make Pt4CL2p-GUS transcriptional fusion binary vector as shown in Fig. 8.
The Pt4CLlp-GUS and Pt4CL2p-GUS constructs were then mobilized into Agrobacterium tumefaciens strain C58/pMP90 by freeze and thaw method as explained previously.
Leaf disk transformation of tobacco with these two Agrobacterium constructs is conducted according to the method of Horsch R.B. (1988) Leaf Disk Transformation, Plant Molecular Biology Manual, A5:1-9.
To further investigate the regulation of the tissue-specific expression of Pt4CL1 and Pt4CL2 genes at the cellular level, their promoter activities were analyzed in transgenic tobacco plants by histochemical staining of GUS gene expression driven by a 1 kb Pt4CL1 and 1.2 kb Pt4CL2 promoter sequences, respectively. In Pt4CLlp-GUS transgenic plants, intense GUS staining was detected in lignifying xylem of stem. Strong GUS activity also was found localized to xylem of leaf mid-rib and of root. However, there was no GUS expression in leaf blade, stem epidermis, cortex, phloem and pith, and flower petal. These results are consistent with the evidence that Pt4CLI gene expression is xylem- or lignifying tissue-specific, and with the observation that Pt4CL1 mRNA level is the highest in aspen secondary developing xylem. In striking contrast to the Pt4CLl promoter activity, the Pt4CL2 promoter did not direct GUS expression in vascular and xylem tissues in the stem and the leaf of Pt4CL23p-GUS transgenic plants. Instead, it directed GUS expression in lignindeficient epidermal cells of the stem (Figure 10C) and ofthe'leaf, reflecting the association of Pt4CL2 with nonlignin-related phenylpropanoid biosynthesis in the plant's outer layers. In addition, GUS staining also was detected in Pt4CL2p-GUS transgenic plant's floral organs, such as stigma and petal, suggesting the likely relevance of Pt4CL2 in mediating the formation of flavonoids, which are known to be accumulated in these organs (Higuchi (1997, supra; Caldwell et al., Physiol. Plant, 58, 455 (1983); Shirley, Trends in Plant Sci., 1, 377 (1996)).
The epidermis-specific Pt4CL2 promoter activity indicated that the in vivo Pt4CL2 mRNA message observed in aspen stem intemodes could be caused by the signal derived from the epidermis RNA. Thus, the specific expression of Pt4CL2 mRNA in epidermis further supports the biochemical functions of Pt4CL2 protein in the biosynthesis of nonlignin-related phenylpropanoids.
Therefore, the promoter fragments incorporated in Pt4CL1p-GUS and Pt4CL2p-GUS fusion genes must encompass the regulatory sequence elements that are responsible for the contrasting tissue-specific expression between Pt4CL1 and Pt4CL2 genes in aspen. Thus, based on both in vivo gene expression and gene promoter activity analyses, it was concluded that the expression of Pt4CL1 and Pt4CL2 genes in aspen is compartmentalized.
These results demonstrate that in aspen two functionally distinct 4CLs are uniquely compartmentalized by their gene regulatory systems for mediating differentially the biosynthesis oflignin and other phenylpropanoids that serve different physiological functions in aspen. Pt4CL1 is involved in channeling hydroxycinnamic acid derivatives to the synthesis of guaiacyl-syringyl lignin in xylem tissues. Pt4CL2 is associated with the biosynthesis of phenylpropanoids other than lignin in epidermal cells in the stem and the leaf, suggesting its likely participation in disease-resistance or defense-related mechanisms in the plant's outer layers. Therefore, 4CL isoforms may have distinct roles in plant defense systems and in lignification in a tissue-specific manner. From a practical point of view, the tissue-specific Pt4CL1 and Pt4CL2 gene promoters may offer a more defined control of future genetic engineering of traits in trees that must be confined to xylem or epidermal cells.
J. Cellulose Accumulation Twenty-five transgenic aspen lines were generated in which Pt4CLI expression was down-regulated to various degrees by antisense inhibition, using a Pt4CLI gene operatively linked to a duplicated enhancer CaMV 35S promoter (Datla et al., Plant Sci., 94, 139 (1993)). The effect of Pt4CL1 deficiency on woody tissue development was investigated in ten-month-old trees. Pt4CL1 messenger RNA was drastically reduced in four lines (Fig. 9A). These lines also exhibited more than a 90% reduction in xylem Pt4CLI enzyme activity (Fig.
9B), and a 40 to 45% reduction in stem lignin (Fig. 9C). A more modest lignin reduction was found in those lines with less drastic repression of Pt4CLl activity. The reduction in lignin content was restricted to woody xylem, as -z.
shown by attenuated lignin autofluorescence in xylem but not in phloem fibers following UV-irradiation (Figs. 9D, Severe repression of other lignin biosynthetic pathway enzymes, such as COMT or CAD, had no effect on lignin quantity in transgenic aspen, hybrid poplar or a loblolly pine (Pinus taeda) mutant (Tsai et al., 1998; VanDoorsselaere et al., Plant 8, 855 (1995); Baucher et al., Plant Physiol., 112, 1479 (1996)). Lignin structure, however, was significantly altered in these cases.
To investigate the effect of Pt4CL1 repression on lignin structure, milled wood lignins were isolated from the stem of a transgenic (line 6 with a lignin reduction) and a control (using methods described in Bjorkman, Nature, 174, 1057 (1954); Chiang et al., Holzforschung, 44, 147 (1990); and Ralph et al., JACS, 116, 9448 (1994)) and then were analyzed by nuclear magnetic resonance (NMR) Examination of HSQC (heteronuclear single-quantum coherence) spectra (Fig. 10) and their HSQC-TOCSY (HSQC-total correlation spectroscopy) counterparts and HMQC (heteronuclear multiple-quantum correlation) indicated that these lignins are structurally similar, consistent with their comparable syringyl-to-guaiacyl ratios based on thioacidolysis of intact stem. The ratios for control and transgenic line 6 were 2.3 and 2.1, respectively.
Thus, there appeared to be little disruption of the normal lignin structure as a result of reduced Pt4CLl activity. It is clear from Figure 10 that P-aryl ethers (P- 0-4) 10, normally the most abundant (50 to 60%) linkage type in tree lignin (Adler et al., Wood Sci. Technol., 11, 169 (1977)), predominate in both lignin samples. In both lignins, erythro-isomers are more prevalent than their threocounterparts, typical of angiosperm lignin. Resinol units (12 Fig. which largely results from coupling of sinapyi alcohol 9b monomers and represent initial intermediates in lignin polymerization reactions in angiosperm trees, are well represented in both lignins. Traces of phenylcoumaran units 11 and a-P-diaryl ethers 14 were detectable in each lignin. Absent from both lignins were condensed biphenyl units such as dibenzodioxocins 13 (Ralph et al., supra). Such units, formed from 5-5-homo-coupling of coniferyl alcohol 9a, normally represent about 4% of the constituents in angiosperm lignin (Adler, supra).
Low levels of4-coumaric 2 and ferulic 4 acids are sometimes detectable in angiosperm lignins. Therefore, it was determined whether the incorporation of these acids was affected by decreased Pt4CLl activity. Long-range 3
C-'H-
correlation (HMQC) NMR experiments revealed that these acids were absent from both lignin samples. However, cell walls oftransgenic stem tissue contained alkaline extractable 4-coumaric 2 and ferulic 4 acids at levels I and higher, respectively, than the control. Alkaline hydrolysis of stem wood meal (pass 80-mesh) was performed at room temperature for 24 hr in 1 N NaOH (Hartley, J. Chromatogr., 54, 335 (1971)). The hydrolysates were neutralized, extracted with ethyl acetate and concentrated. The concentrated products were derivatized with BSTFA and analyzed by GC-MS in SIM (selected ion monitoring) mode using a DB-5 column. 4-Coumaric acid 2 (TMS-derivative; m/z 308) content of control was 199 13 nmol/g dry wood, and 2145 93 nmol/g dry wood in transgenic line 6. Ferulic acid 4 (TMS-derivative: m/z 338) contents in control and transgenic line 6 were 510 9 and 2431 120 nmol/g dry wood, respectively. No sinapic acid 6 (TMS-derivative: m/z 368) could be detected in control. However, a significant amount of sinapic acid, 2452 119 nmol/g dry wood, was found in transgenic line 6.
Together, the lignin and cell wall analyses support a requirement for activation by Pt4CL1 of these phenolic acids for their incorporation into lignin.
The cell wall apparently serves as a sink for accumulating these acids when Pt4CL1 activity is reduced. As a result, lignin content was reduced in the transgenic line but lignin composition and structure were not significantly altered. The conservation of normal lignin composition and structure in the transgenic aspen stands in sharp contrast to the marked changes of lignin composition and structure in other transgenic and mutant plants with altered lignin biosynthesis (Tsai et al., 1998; Van Doorsselaere et al., 1995; Baucher et al., 1996; Elkind et al., Proc. Natl. Acad. Sci. USA, 87, 9057 (1990); Piquemal et al., Plant 13, 17 (1998); Sewalt et al., Plant Physiol., 115, 41 (1997); Kajita et al., Plant Physiol., 114, 871 (1997); Lee et al., Plant Cell, 9, 1985 (1997); Dwivedi et al., Plant Mol. Biol., 26, 61 (1994); Ni et al., Transgenic Res., 3, 120 (1994); Atanassova et al., Plant 8, 465 (1995); Halpin et al., Plant 6, 339 (1994); Hibino et al., Biosci. Biotech. Biochem., 59, 929 (1995)). The results are consistent with the supposition that 4CL modulates lignin accumulation in trees in a regulatory manner that does not result in disruption of lignin structure.
Lignin and polysaccharides are proposed to account for the remarkable mechanical strength of woody tissues (White et al., Nature, 205, 818 (1965); Atalla et al., Science, 227, 636 (1985); Houtman et al., Plant Physiol., 107, 977 (1995); Taylor et al., Plant 2, 959 (1992); Turner et al., Plant Cell, 9, 689 (1997)). In consideration of the possible effects of severe lignin reduction on structural polysaccharide components, these components were examined in stem wood tissue. While hemicellulose content remained essentially unchanged, the transgenic lines had a 9 to 15% increase in glucan (Table identified as P- (1-4)-glucan, or cellulose, by methylation-based linkage analysis and enzymatic hydrolysis. Lignin content was determined as the sum of Klason and acidsoluble lignins which represent the absolute quantity of lignin (Chiang et al., Holzforschung, 44, 147 (1990)). Cellulose and hemicelluloses contents were determined based on the total sugars after acid hydrolysis of these polysaccharides in stem woody tissue (Chiang et al., Wood Sci. Technol., 17, 217 (1983); Pettersen et al., J. Wood Chem. Technol., 11,495 (1991)). Wood meal (pass 80-mesh) was vacuum-dried at 45 0 C and hydrolyzed with H,SO 4 Sugar contents of the hydrolysates were determined by anion exchange high performance liquid chromatography using pulsed amperometric detection and used for quantifying glucan and other polysaccharides (hemicelluloses) (Davis, J.
Wood Chem. Technol., 18,235 (1998)).
The dried wood meal was also used for methylation analysis of the glucan in wood. Both the Hakomori Biochem. Tokyo, 55, 205 (1964)) and NaOH/CH 3 I (Ciucanu et al., Carbohydr. Res., 131, 209 (1984)) methylation procedures were followed. Methylated samples were hydrolyzed in 2M TFA at 121 C for 2 hr, reduced with sodium borodeuteride, and acetylated using acetic anhydride at 120°C for 3 hr. The derivatized samples were analyzed by GC-MS using a Sp2330 Supelco column. The methylation revealed that the glucose residues are mainly derived from 1-4 glucan for both control and transgenic lines. Enzymatic hydrolysis of stem woody tissue further confirmed that the glucans in both control and transgenic lines are P-(l-'4)-glucan, or cellulose.
Thus, (1-3)-linked glucan (callose), reportedly deposited in plant cell walls as a result of perturbed secondary metabolism (Schmelzer et al., Plant Cell, 1, 993 (1989)), was not detected in transgenic or control wood. Together, increased cellulose and decreased lignin content resulted in a cellulose-to-lignin ratio of 4 compared with 2 in control aspen (Table The reason for the increased cellulose content is not clear. The absence of change in transcript levels of an aspen homolog of celA encoding a catalytic subunit of cellulose synthase (Arioli et al., Science, 279, 717 (1997)) argues against an increase in the rate of cellulose deposition due to altered transcriptional regulation in transgenic trees with reduced lignin content. The increase in cellulose content suggests that cross talk between lignin and cellulose biosynthetic pathways can nevertheless occur to ensure that cellulose biosynthesis becomes the preferred structural carbon sink when lignin biosynthesis is reduced. Because cellulose and lignin are the two components of wood most responsible for its rigidity, such cross talk could represent an adaptation to sustain mechanical strength in lignin deficient xylem.
The reduced lignin content in transgenic lines did not adversely affect tree growth and development. In fact, trees with down-regulated Pt4CLI had thicker stems, longer internodes, and larger (frequently epinastic) leaves than controls (Figs. 11A and 11B). Scanning electron microscopy (SEM) revealed that the shape and size of stem xylem fiber and vessel cells were similar to those of controls (Figs. 11C-F). Therefore, the enhanced stem development in these transgenic lines was apparently due to increased proliferative activity during xylem development rather than to increased cell size. Root growth rates also increased in these lines, resulting in greater length (15-fold) and fresh weight gain (20-fold) than in controls over a 14-day period in ex vitro rooting experiments (Fig. 11G). Cell size distribution in the meristematic and elongation zones of root tips was similar in control and transgenic roots. As was the case in stem xylem, increased root growth rate of the transgenic was due to increased cell number. Leaf growth also increased in the transgenic lines resulting in 4- to larger leaves than in controls (Fig. 1 IB). Mature leafadaxial epidermal cells were measured in two of the transgenic lines and found to be at least twice as large as in control aspen. A more detailed analysis was conducted to determine whether the rate and/or the duration of cell expansion accounted for the increased cell size in mature leaves of transgenic aspen. Epidermal cell expansion stopped at leaf number 15 below the first emerging leaf in control plants, but epidermal cells as well as leaf area continued to expand at leaf number 28 in transgenics (Fig. 11H). Therefore, the prolonged expansion of epidermal cells contributed to increased leaf size in the transgenic aspen lines.
The promotive effects on growth and development in the transgenic trees was a surprising observation. Growth enhancement has not been reported in transgenic tobacco or Arabidopsis with downregulated PAL (phenylalanine ammonia lyase), CCR, C4H, 4CL, COMT, or CAD. In fact, stunted growth and collapsed cell walls occurred in some transgenic tobacco with altered lignin biosynthesis. Whether the growth responses between herbaceous and tree species differed due to altered lignin biosynthesis per se is not clear. In the case of aspen, lignin composition and structure were conserved, eliminating the possibility that altered lignin constituents promoted growth. In aspen trees, reduced expression of Pt4CL1 disrupted lignin biosynthesis downstream of the phenylpropanoid pathway and this increased the concentration of phenylpropanoid intermediates in cell walls. At the same time, enhanced cell division and cell expansion were observed in root tips and leaves. Whether the growth enhancement observed in the transgenic aspen is due to altered carbon distribution between primary/secondary metabolism or specifically due to changes in wall-bound moieties are two possibilities to consider. Histone gene(s) expression has been used as a marker to show that cell division decreases in suspension cells and young leaves of parsley following treatments of that divert carbon flow in to the phenylpropanoid pathway and away from primary metabolic pathways (Logemann et al., Plant 8, 865 (1995)). There is also current interest in the organization and composition of cell wall constituents and their effects on cell expansion and plant growth. For these rationale,
L
I
phenylpropanoid flux as well as cell wall constituents would be of interest for investigating growth effects of lignin manipulation in trees.
The finding that cellulose content increases in transgenic aspen with disrupted lignin biosynthesis is unique; similar observations have not been reported in herbaceous plants (Turner et al., Plant Cell, 9, 689 (1997); Elkind et al., 1990; Piquemal et al., 1998)). Interesting to consider is the idea that in perennial woody plants, lignin and cellulose deposition in cell walls are regulated in a compensatory fashion such that decreased in one are compensated for by increases in the other for maintaining the cellular structural integrity. This compensatory deposition of lignin and cellulose is consistent with the manner of how trees regulate their lignin and cellulose quantities in the course of forming naturally occurring reaction wood for mechanical support. Compensatory regulation such as this would also provide metabolic flexibility during annual growth increments, perhaps key for the long term structural integrity of woody perennials like trees. Further study is required to determine whether such regulation of cellulose accumulation is sensitive to primary/secondary metabolism and to changes in cell wall constituents such as those observed in Pt4CL1 down-regulated aspen.
Overall, lignin limits the utilization of wood for fiber/material-, chemical-, and energy-production. Traditional breeding approaches have not led to trees with more desirable lignin/cellulose composition. However, genetic engineering appears to offer a strategy for manipulating such traits in trees, with the prospect ofsystemically regulating growth as reported here. The benefit of these engineered traits may also extend to forage crops in which lignin has been identified as the major barrier to their digestibility by ruminants.
Table 7. Lignin and cellulose contents in stem woody tissue of control and transgenic aspen. Data are the mean SD of three independent experiments.
Normalized values relative to control are shown in parentheses.
Lignin Content Cellulose Content Cellulose-to- Line of dry wood weight) of dry wood weight) lignin ratio Control 21.62 0.30 (100) 44.23 0.43 (100) 4 12.83 0.28 (60) 48.35 0.60 (109) 3.8 13.02 0.28 (60) 49.74 0.45 (112) 3.7 6 11.84 0.08 (55) 50.83 0.26 (115) 4.3 8 12.90 ±0.04 (60) 48.14 ±0.29 (109) 3.8 All publications and patents are incorporated by reference herein, as though individually incorporated by reference, as long as they are not inconsistent with the present disclosure. The invention is not limited to the exact details shown and described, for it should be understood that many variations and modifications may be made while remaining within the scope of the invention defied by the claims.
Claims (25)
1. A method of imparting disease resistance to a plant tissue comprising: introducing an expression cassette comprising a recombinant DNA molecule comprising a nucleotide sequence encoding a 4- coumarate Co-enzyme A ligase operably linked to a promoter functional in a plant cell into cells of a plant; regenerating said plant cells to provide a transgenic plant; and expressing the recombinant DNA molecule in the cells of the transgenic plant in an amount effective to render the plant resistant to disease.
2. The method according to claim 1, wherein the disease is caused by a fungus.
3. nucleotide sequence The method according to claim 1 or claim 2, wherein the is in the antisense orientation.
4. A transgenic plant prepared by the method according to any one of claims 1 to 3. A transgenic seed of the transgenic plant according to claim 4.
6. A transgenic plant, which plant is substantially resistant to disease, comprising: (a) (b) a native 4-coumarate Co-enzyme A ligase gene, and a recombinant DNA molecule comprising a nucleotide sequence encoding 4-coumarate Co-enzyme A ligase operably linked to a promoter functional in a plant wherein the recombinant DNA molecule is expressed in an amount effective to confer resistance to the transgenic plant. A method for altering the cellulose content in a plant comprising: introducing an expression cassette comprising a recombinant DNA molecule comprising a nucleotide sequence encoding a 4- coumarate Co-enzyme A ligase operably linked to a promoter H:\deborahk\keep\speci\2003 2 48405.doc 24/05/06 40 Sfunctional in a plant cell into the cells of a plant; regenerating said plant cells to provide a transgenic plant; and expressing the recombinant DNA molecule in the cells of the transgenic plant in an amount effective to alter the cellulose CN 5 content in the plant.
8. A transgenic plant having a altered cellulose content in the plant Scells comprising: a recombinant DNA molecule comprising a recombinant DNA 0 molecule sequence encoding a plant 4-coumarate Co-enzyme A ligase operably linked to a promoter so that the recombinant DNA molecule is expressed in an amount O effective to alter the cellulose content of the plants.
9. A method of altering cellulose content in a plant, comprising the step of incorporating into the genome of the plant an exogenous polynucleotide encoding p-coumarate Co-enzyme A ligase (4CL), such that when the polynucleotide is expressed in the plant, the plant exhibits altered cellulose, relative to a control plant lacking the exogenous polynucleotide. The method according to claim 9, wherein cellulose is increased.
11. The method according to claim 9, wherein cellulose is decreased.
12. The method according to any one of claims 9 to 11, wherein the plant is a woody species.
13. The method according to any one of claims 9 to 12, wherein the plant is a tree.
14. The method according to any one of claims 9 to 13, wherein the plant is an angiosperm. The method according to any one of claims 9 to 13, wherein the plant is a gymnosperm.
16. The method according to any one of claims 9 to 15, wherein the H:\deborahk\keep\speci\2003 2 48405.doc 24/05/06 41 plant is a member of a species selected from the group consisting of Pinus species, Callitris species, Picea species, Pseudotsuga species, Tsuga species, Eucalyptus species, Juglans species, Carya species, Ulmus species, Quercus species, Casuarina species, Populus species, Acacia species, Liquidamber species, Corymbria species, N 5 Lirodendron species, Acer species, and Betula species.
17. A plant made by a method according to any one of claims 9 -to 16. 00 10 18. A method of altering lignin content in a woody Splant, comprising the step of incorporating into the genome of the plant an exogenous C1 polynucleotide encoding p-coumarate Co-enzyme A ligase (4CL), such that when the polynucleotide is expressed in the plant, the plant exhibits altered lignin content, relative to a control plant lacking the exogenous polynucleotide.
19. The method according to claim 18, wherein the plant is a gymnosperm. The method according to claim 18, wherein the plant is an angiosperm.
21. The method according to any one of claims 18 to 20, wherein the plant is a tree.
22. The method according to any one of claims 18 to 21, wherein the plant is a member of a species selected from the group consisting of Pinus species, Callitris species, Picea species, Pseudotsuga species, Tsuga species, Eucalyptus species, Juglans species, Carya species, Ulmus species, Quercus species, Casuarina species, Populus species, Acacia species, Liquidamber species, Corymbria species, Lirodendron species, Acer species, and Betula species.
23. The method according to any one of claims 18 to 22, wherein the lignin content is decreased.
24. The method according to any one of claims 18 to 22, wherein the lignin content is increased. H;\deborahk\keep\speci\2003 2 48405.doc 24/05/06 42 0
25. A plant made by a method according to any one of claims 18 to 24.
26. A method of altering lignin content in a N 5 gymnosperm, comprising the step of incorporating into the genome of the plant an exogenous polynucleotide encoding p-coumarate Co-enzyme A ligase (4CL), such that tIn when the polynucleotide is expressed in the plant, the plant exhibits altered lignin content, relative to a control plant lacking the exogenous polynucleotide. 00
27. The method according to claim 26, wherein the plant is a 0 woody plant.
28. The method according to claim 26 or claim 27, wherein the plant is a tree.
29. The plant made by a method according to any one of claims 26 to 28. A method of altering lignin structure in a woody plant, comprising the step of incorporating into the genome of the plant an exogenous polynucleotide encoding p-coumarate Co-enzyme A ligase (4CL), such that when the polynucleotide is expressed in the plant, the plant exhibits altered lignin content, relative to a control plant lacking the exogenous polynucleotide.
31. A transgenic plant according to claim 6 or claim 8, substantially as herein described with reference to the drawings.
32. A method according to any one of claims 1, 7, 9, 18, 26 or substantially as herein described with reference to the drawings. Dated this 25th day of May 2006 BOARD OF CONTROL OF MICHIGAN TECHNOLOGICAL UNIVERSITY By their Patent Attorneys GRIFFITH HACK Fellows Institute of Patent and Trade Mark Attorneys of Australia H:\deborahk\keep\speci\2003 2 48405.doc 24/05/06
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/969046 | 1997-11-12 | ||
| PCT/US1998/024138 WO1999024561A2 (en) | 1997-11-12 | 1998-11-12 | Genetic engineering of lignin biosynthesis in plants |
| AU14024/99A AU762576B2 (en) | 1997-11-12 | 1998-11-12 | Genetic engineering of lignin biosynthesis in plants |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU14024/99A Division AU762576B2 (en) | 1997-11-12 | 1998-11-12 | Genetic engineering of lignin biosynthesis in plants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003248405A1 AU2003248405A1 (en) | 2003-11-06 |
| AU2003248405B2 true AU2003248405B2 (en) | 2006-08-31 |
Family
ID=39364019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003248405A Ceased AU2003248405B2 (en) | 1997-11-12 | 2003-09-26 | Genetic engineering of lignin biosynthesis in plants |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2003248405B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110396522B (en) * | 2018-04-23 | 2023-03-28 | 中国科学院分子植物科学卓越创新中心 | Application technology for regulating and controlling lignin to improve yield of root crops |
| CN118614349B (en) * | 2024-06-04 | 2025-11-11 | 河南省畜牧技术推广总站 | High-yield cereal grass planting method for herbivore feed |
| CN119979748B (en) * | 2024-12-09 | 2025-09-19 | 北京林业大学 | Application of a Pto-C3H35 gene haplotype in evaluating the lignin content of poplars |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1083600A (en) * | 1998-10-09 | 2000-05-01 | Arborgen Llc | Materials and methods for the modification of plant lignin content |
-
2003
- 2003-09-26 AU AU2003248405A patent/AU2003248405B2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1083600A (en) * | 1998-10-09 | 2000-05-01 | Arborgen Llc | Materials and methods for the modification of plant lignin content |
Non-Patent Citations (2)
| Title |
|---|
| Plant Cell Physiolo. 37(7):957-65, * |
| Plant Mol. Biol. 28:871-84, * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003248405A1 (en) | 2003-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2309337C (en) | Genetic engineering of lignin biosynthesis in plants | |
| Atanassova et al. | Altered lignin composition in transgenic tobacco expressing O‐methyltransferase sequences in sense and antisense orientation | |
| Whetten et al. | Lignin biosynthesis | |
| Piquemal et al. | Down-regulation of cinnamoyl-CoA reductase induces significant changes of lignin profiles in transgenic tobacco plants. | |
| US6855864B2 (en) | Methods for simultaneous control of lignin content and composition, and cellulose content in plants | |
| US7888553B2 (en) | Method for modifying lignin composition and increasing in vivo digestibility of forages | |
| AU2001288765A1 (en) | Genetic engineering of syringyl-enriched lignin in plants | |
| AU2001247731B2 (en) | Method for modifying lignin composition and increasing in vivo digestibility of forages | |
| AU2001247731A1 (en) | Method for modifying lignin composition and increasing in vivo digestibility of forages | |
| Rastogi et al. | Down‐regulation of lignin biosynthesis in transgenic Leucaena leucocephala harboring O‐methyltransferase gene | |
| Prashant et al. | Down-regulation of Leucaena leucocephala cinnamoyl CoA reductase (LlCCR) gene induces significant changes in phenotype, soluble phenolic pools and lignin in transgenic tobacco | |
| US7807880B2 (en) | Modification of plant lignin content | |
| AU2003248405B2 (en) | Genetic engineering of lignin biosynthesis in plants | |
| EP1791417B1 (en) | Polynucleotides, DNA constructs and methods for the alteration of plant lignin content and/or composition | |
| Grimmig et al. | Expression of BifunctionaI Caffeoyl‐CoA 3‐O‐Methyltransferase in Stress Compensation and Lignification | |
| Chiang et al. | Genetic engineering of plants through manipulation of lignin biosynthesis | |
| CA2626408A1 (en) | Non-plant sucrose synthase polynucleotides, dna constructs and methods for the alteration of cellulose content in plants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |